What is Cannonau Corp. (CNNC) stock price today?

Cannonau Corp. (CNNC) is currently trading at $0.00.

What is CNNC return on equity (ROE)?

Cannonau Corp.'s return on equity (ROE) is -114.55%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.

What is Cannonau Corp.'s market cap?

Cannonau Corp. has a market capitalization of $72413.

OTC · Drug Manufacturers - Specialty & Generic

Cannonau Corp. (CNNC) Stock

$0.00 OTC: CNNC Healthcare

Cannonau Corp. specializes in the development and marketing of products based on cannabidiol.

Valuation

Metric	Value
Price	$0.00
Market Cap	$72413
P/E Ratio	0.00
P/B Ratio	0.00
P/S Ratio	0.00
EPS (TTM)	$0.00
52-Week High	$0.04
52-Week Low	$0.00
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-114.55%
ROA	—
ROCE	7.21%
Gross Margin	0.00%
Operating Margin	0.00%
Net Margin	0.00%
Debt/Equity	0.00
Current Ratio	0.03

Annual Financials (USD)

Metric	2019	2020	2021	2022	2023
Revenue	$0	$0	$0	$0	$0
Operating Profit	$0	$0	$0	$0	$0
Net Profit	$0	$0	$0	$0	$0
EPS	$-1.48	$-0.07	$-0.06	$-0.04	$0.14
Op Margin	—	-4715.7%	-2411.0%	-37863.4%	—

Balance Sheet (USD)

Metric	2019	2020	2021	2022	2023
Total Assets	$0	$0	$0	$0	—
Total Liabilities	$0	$0	$0	$0	—
Cash	$0	$0	$0	$0	—
Borrowings	$0	$0	$0	$0	$0

Cash Flow (USD)

Metric	2019	2020	2021	2022	2023
Operating Cash Flow	$0	$0	$0	$0	$0
Investing Cash Flow	$0	$0	$0	$0	$0
Financing Cash Flow	$0	$0	$0	$0	$0
Net Cash Flow	$0	$0	$0	$0	$0
Free Cash Flow	$0	$0	$0	$0	$0

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.00
EV / EBITDA	0.21
FCF Yield	-0.22%
Quick Ratio	0.01
Interest Coverage	—
Return 1Y	200.00%
Return 3Y	-97.86%
Return 5Y	-99.75%

Ownership

Insiders Held91.16%

Institutions Held0.00%

Institutions Float Held0.00%

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
ACURAcura Pharmaceuticals, Inc.	$0.00	—	0.00	$6600	0.00%
AZFLAmazonas Florestal, Ltd	$0.00	—	—	$25088	0.00%
CBDXCurative Biosciences, Inc.	$0.00	—	-0.03	$3157	0.00%
FIORFFiore Cannabis Ltd.	$0.00	—	0.00	$1971	0.00%
FLHLFFilament Health Corp.	$0.00	—	-1.89	$26179	0.00%

About Cannonau Corp.

Cannonau Corp. specializes in the development and marketing of products based on cannabidiol. The company, which was established in 2007, previously operated as Pacific Blue Energy Corp. before officially rebranding to Cannonau Corp. in August 2019. Its operations are headquartered in Skaneateles, New York.

Cannonau Corp. (CNNC) stock trades at $0.00 with a market capitalization of $72413. The stock is valued at price-to-book of 0.00, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.04, and currently trades 100.0% below its 52-week high.

On profitability, Cannonau Corp. generates a return on equity (ROE) of -114.55% (negative, reflecting a net loss), return on capital employed of 7.21%.

Official website: cannonau.biz

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Related stock screens

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks All stock screens

Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.